TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Details
01. General Information
Name T0901317
PubChem CID 447912
Molecular Weight 481.3g/mol
Synonyms

293754-55-9, T0901317, T 0901317, TO-901317, T-0901317, N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-N-(2,2,2-trifluoroethyl)benzenesulfonamide, Benzenesulfonamide, N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-, N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE, N-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)-N-(2,2,2-trifluoroethyl)benzenesulfonamide, TO901317, CHEMBL62136, T-1317, ML125, A07663A39I, N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]benzenesulfonamide, N-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-propan-2-yl)phenyl)-N-(2,2,2-trifluoroethyl)benzenesulfonamide, [3H]T0901317, SR-05000000453, C17H12F9NO3S, UNII-A07663A39I, 1pqc, BENZENESULFONAMIDE, N-(2,2,2-TRIFLUOROETHYL)-N-(4-(2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL)PHENYL)-, N-(2,2,2-TRIFLUOROETHYL)-N-(4-(2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL)PHENYL)BENZENESULFONAMIDE, 2o9i, 4nb6, TO 901317, T 1317, MLS002554297, SCHEMBL457231, GTPL2755, DTXSID6040618, BDBM19993, GLXC-02675, HMS3268P10, HMS3413I08, HMS3649G14, HMS3652B22, HMS3677I08, HMS3886B11, BCP03658, EX-A1278, MFCD03412028, s7076, AKOS017345034, CCG-269558, CS-5951, DB07080, SB19595, NCGC00159555-01, NCGC00159555-02, NCGC00159555-03, NCGC00159555-06, AC-32646, Benzenesulfonamide,N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-, HY-10626, SMR001456586, BCP0726000164, NS00068651, SW203816-2, J1.503.100J, C74506, A876482, J-017492, SR-05000000453-1, SR-05000000453-2, SR-05000000453-5, T-901317, BRD-K23383398-001-01-6, Q27088909, T0901317, >=98%, Benzenesulfonamide,?N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-, N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide, N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-N-(2,2, 2-trifluoroethyl)benzenesulfonamide

Drug Type Small molecule
Formula C₁₇H₁₂F₉NO₃S
SMILES C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O
InChI 1S/C17H12F9NO3S/c18-14(19,20)10-27(31(29,30)13-4-2-1-3-5-13)12-8-6-11(7-9-12)15(28,16(21,22)23)17(24,25)26/h1-9,28H,10H2
InChIKey SGIWFELWJPNFDH-UHFFFAOYSA-N
CAS Number 293754-55-9
ChEMBL ID CHEMBL62136
TTD ID D0B5FC
Drug Bank ID DB07080
KEGG ID C15630
Toxicity Organism Test Type Route(Dose)
Structure 2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 913
Pair Name Lycopene, T0901317
Partner Name Lycopene
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Inhibition-->Cell proliferation
Gene Regulation Up-regulation Expression ABCA1 hsa19
Up-regulation Expression NR1H3 hsa10062
Up-regulation Expression PPARG hsa5468
In Vitro Model DU145 Prostate carcinoma Homo sapiens (Human) CVCL_0105
PC-3 Prostate carcinoma Homo sapiens (Human) CVCL_0035
Result These results demonstrate that lycopene can inhibit DU145 cell proliferation via PPARγ-LXRα-ABCA1 pathway and that lycopene and T0901317 exhibit synergistic effects.
03. Reference
No. Title Href
1 Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway. J Nutr Biochem. 2012 Sep;23(9):1155-62. doi: 10.1016/j.jnutbio.2011.06.009. Click
It has been 48352 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP